Gleason Grade Group 4 prostate biopsy with no cancer seen on final pathology in the magnetic resonance imaging and Prostate Specific Membrane Antigen-Positron Emission Tomography era.
IJU Case Rep
; 6(6): 337-340, 2023 Nov.
Article
em En
| MEDLINE
| ID: mdl-37928279
ABSTRACT
Introduction:
The absence of prostate cancer on final surgical pathology after biopsy-proven prostate cancer is a rare finding. Case presentation Case of pT0 prostate cancer following Gleason Grade Group 4 in 1 out of 12 cores from a transrectal ultrasound-guided biopsy in a man who underwent both magnetic resonance imaging and 18F-PSMA-1007 Positron Emission Tomography prior to radical prostatectomy.Conclusion:
pT0 prostate cancer is rare. The use of novel imaging modalities may help in the workup of prostate cancer.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Idioma:
En
Ano de publicação:
2023
Tipo de documento:
Article